Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Social Buzz: WallStreetBets Crowd Gets Bullish Off the Opening Bell; Omicron Fighters Get Top Billing

11/29/2021 | 09:49am EST


ę MT Newswires 2021
All news about MODERNA, INC.
01/16India's Gennova working on Omicron-specific COVID-19 vaccine - source
RE
01/16OMICRON-SPECIFIC VACCINE LIKELY TO C : Sharma
AQ
01/14INSIDER SELL : Moderna
MT
01/14Denver International Airport to Host COVID-19 Vaccine Booster Clinics for Employees and..
AQ
01/14Uganda to Destroy 400,000 Covid-19 Vaccines That Are Due to Expire
AQ
01/13Health Care Down Amid Valuation Concerns -- Health Care Roundup
DJ
01/13Today on Wall Street: Time for a new chapter?
01/13EUROPEAN MIDDAY BRIEFING - Stocks Down, Investors -2-
DJ
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/13New data finds AstraZeneca booster generates higher antibodies against Omicron
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 480 M - -
Net income 2021 11 079 M - -
Net cash 2021 9 706 M - -
P/E ratio 2021 7,75x
Yield 2021 -
Capitalization 83 008 M 83 008 M -
EV / Sales 2021 4,19x
EV / Sales 2022 2,97x
Nbr of Employees 1 300
Free-Float -
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 204,73 $
Average target price 273,06 $
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%52 584
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684
CELLTRION, INC.-13.64%20 026